Dupilumab: Mit dualer Rezeptorblockade schweres Asthma mit Typ-2-Inflammation besser kontrollieren
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 32
(3)
◽
pp. 14-14
Keyword(s):
Keyword(s):